Page last updated: 2024-08-17

spironolactone and dimethylarginine

spironolactone has been researched along with dimethylarginine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimura, K; Futatsugi, K; Hasegawa, K; Hayashi, K; Hosoya, K; Itoh, H; Kanda, T; Komatsu, M; Minakuchi, H; Shinozuka, K; Tokuyama, H; Wakino, S; Washida, N; Yoshifuji, A1

Trials

1 trial(s) available for spironolactone and dimethylarginine

ArticleYear
Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans.
    Kidney international, 2015, Volume: 87, Issue:4

    Topics: Adipose Tissue; Aged; Aldosterone; Amidohydrolases; Animals; Arginine; Cell Nucleus; Cytochrome P-450 CYP11B2; Female; Glomerular Filtration Rate; Glucose Tolerance Test; Homeostasis; Humans; Immediate-Early Proteins; Insulin Resistance; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nephrectomy; Oxidative Stress; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renal Insufficiency, Chronic; Renin; Signal Transduction; Spironolactone

2015